When combined with GLP-1 medications, it helps ensure the weight you're losing comes primarily from fat stores
FDA has oversight for the integrity and safety of the drugs (called Active Pharmaceutical Ingredients, or APIs, by FDA) used in compounded preparations
This piece is written for researchers, clinicians, and scientifically literate readers who want an accurate map: what retatrutide is, why insulin resistance drives PCOS, what the compound has genuinely shown (and in whom), what the closest analog class GLP-1 receptor agonists has shown in actual PCOS trials, how much of any benefit is likely to be weight-mediated versus weight-independent, how it stacks up against the insulin-sensitizing tools PCOS guidelines already endorse, and where the safety and regulatory lines fall
[21] The same adherence dynamic applies to sermorelin
Health insurers can also proactively engage with patients to provide counselling on treatment, administration, and possible side effects
Xia X, Zhang S, Zhang H, Zhang Z, Chen N, Li Z, et al